secwatch.observer — SEC 8-K summary
======================================

Issuer:     RANGE IMPACT, INC. (RNGE)
CIK:        0001438943
Form:       8-K
Filed at:   2021-08-20T23:59:59+00:00
Accession:  0001493152-21-020766
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vitality Biopharma enters $5M equity line at 85% discount with warrants
-----------------------------------------------------------------------

- Shares sold at 85% of lowest 5-day VWAP; warrants at 115% of same VWAP.
- Drawdowns limited to $250K per notice; financing expires Dec 31, 2022 or $5M total.
- Proceeds to advance VBX-100 prodrug preclinical studies and general corporate purposes.
- VBX-100 granted FDA Orphan Drug Designation for pediatric ulcerative colitis.
- Institutional investor's beneficial ownership capped at 9.99% for shares, 4.99% for warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438943/000149315221020766/0001493152-21-020766-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438943/000149315221020766/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-020766

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer